ClinicalTrials.Veeva

Menu

Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial

C

Capt Alicia Prescott

Status

Completed

Conditions

Anemia

Treatments

Procedure: Drawing admission labs from cord blood
Procedure: Drawing admission labs from infant blood

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT02103296
393720-1

Details and patient eligibility

About

The goal of this protocol is to establish a randomized clinical trial comparing the use of cord blood vs. infant blood with the primary outcome of comparing both the absolute hemoglobin concentration and the percent change in hemoglobin concentration from baseline around 24 hours of life.

Enrollment

80 patients

Sex

All

Ages

Under 1 day old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Birth weight less than 1200g or Gestational Age less than 30 weeks born at participating medical centers

Exclusion criteria

  • No specific exclusion criteria

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Infant Blood
Active Comparator group
Description:
Control group. Admission labs to be drawn directly from the infant.
Treatment:
Procedure: Drawing admission labs from infant blood
Cord Blood
Experimental group
Description:
Admission labs to be drawn from the infant's cord blood
Treatment:
Procedure: Drawing admission labs from cord blood

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems